EMS 12-Lead
APRIL 14, 2022
ACE inhibitors, or potassium-sparing diuretics), are particularly susceptible. A brief review of the pathophysiology of hyperkalemia will help set the stage for the ECG changes inherent therein. Other causes include metabolic acidosis, in which hydrogen ions shift into the cells in exchange for potassium. McCance, K. & Huether, S.
EMS 12-Lead
MAY 8, 2022
ACE inhibitors, or potassium-sparing diuretics), are particularly susceptible. This ECG is pathognomonic for hyperkalemia. Predisposition to hyperkalemia is complex, but in general, patients with renal disease, or those taking medications that yield potassium retention (e.g. Elsevier-Saunders: Philadelphia, PA. [6]. McCance, K.
Dr. Smith's ECG Blog
NOVEMBER 15, 2023
associated typical Myocardial Infarction therapies such as statins and ACE inhibitors with significantly decreased 1 year mortality in MINOCA patients, which suggests that they do indeed have a similar pathophysiology to MI patients with obstructive coronary disease. Lindahl et al.
Dr. Smith's ECG Blog
SEPTEMBER 30, 2019
The patient stated he had a long history of well-controlled hypertension for which he was compliant with his ACE-inhibitor. His pain radiated to his shoulders throughout the evening and the night but it did not prompt him to seek medical attention. He was also treated for erectile dysfunction but had not taken any medications recently.
Dr. Smith's ECG Blog
NOVEMBER 30, 2022
associated typical Myocardial Infarction therapies such as statins and ACE inhibitors with significantly decreased 1 year mortality in MINOCA patients, which suggests that they do indeed have a similar pathophysiology to MI patients with obstructive coronary disease. Lindahl et al.
Expert insights. Personalized for you.
52 
Let's personalize your content